Erlotinib
Erlotinib Brand Name– Tarceva What is Erlotinib Erlotinib is an oral, selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) that is FDA-approved as monotherapy for the treatment of metastatic non-small cell lung cancer (NSCLC) in patients with EGFR exon 19 deletions or exon 21 (L858R) substitution mutations and in combination with gemcitabine for the treatment …
